[11C]CPPC Injection

DRUG2 trials

Sponsors

Johns Hopkins University

Conditions

Amyotrophic Lateral SclerosisCOVID Long-Haul

Early Phase 1

Long COVID-19 [11C]CPPC Study

CompletedNCT06223971

Johns Hopkins UniversityCOVID Long-Haul

Start: 2024-08-06End: 2026-03-31Updated: 2026-04-30

Phase 1

Study of [11C]CPPC to Assess the Safety and Tolerability in Patients With ALS

TerminatedNCT04749433

Johns Hopkins UniversityAmyotrophic Lateral Sclerosis

Start: 2021-09-01End: 2023-03-30Updated: 2024-10-08